Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 412

1.

Mutations in foregut SOX2+ cells induce efficient proliferation via CXCR2 pathway.

Hishida T, Vazquez-Ferrer E, Hishida-Nozaki Y, Sancho-Martinez I, Takahashi Y, Hatanaka F, Wu J, Ocampo A, Reddy P, Wu MZ, Gerken L, Shaw RJ, Rodriguez Esteban C, Benner C, Nakagawa H, Guillen Garcia P, Nuñez Delicado E, Castells A, Campistol JM, Liu GH, Izpisua Belmonte JC.

Protein Cell. 2019 Apr 30. doi: 10.1007/s13238-019-0630-3. [Epub ahead of print]

PMID:
31041783
2.

One-Time Fecal Immunochemical Screening for Advanced Colorectal Neoplasia in Patients with CKD (DETECT Study).

Wong G, Hope RL, Howard K, Chapman JR, Castells A, Roger SD, Bourke MJ, Macaskill P, Turner R, Williams G, Lim WH, Lok CE, Diekmann F, Cross NB, Sen S, Allen RDM, Chadban SJ, Pollock CA, Tong A, Teixeira-Pinto A, Yang JYH, Williams N, Au EHK, Kieu A, James L, Craig JC.

J Am Soc Nephrol. 2019 Apr 30. pii: ASN.2018121232. doi: 10.1681/ASN.2018121232. [Epub ahead of print]

PMID:
31040191
3.

Reduction of faecal immunochemical test false-positive results using a signature based on faecal bacterial markers.

Malagón M, Ramió-Pujol S, Serrano M, Serra-Pagès M, Amoedo J, Oliver L, Bahí A, Mas-de-Xaxars T, Torrealba L, Gilabert P, Miquel-Cusachs JO, García-Nimo L, Saló J, Guardiola J, Piñol V, Cubiella J, Castells A, Aldeguer X, Garcia-Gil J.

Aliment Pharmacol Ther. 2019 Jun;49(11):1410-1420. doi: 10.1111/apt.15251. Epub 2019 Apr 25.

PMID:
31025420
4.

Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia.

Vila-Navarro E, Duran-Sanchon S, Vila-Casadesús M, Moreira L, Ginès À, Cuatrecasas M, Lozano JJ, Bujanda L, Castells A, Gironella M.

Clin Transl Gastroenterol. 2019 Apr;10(4):e00029. doi: 10.14309/ctg.0000000000000029.

PMID:
31009404
5.

Correction: Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer.

Herreros-Villanueva M, Duran-Sanchon S, Martín AC, Pérez-Palacios R, Vila-Navarro E, Marcuello M, Diaz-Centeno M, Cubiella J, Diez MS, Bujanda L, Lanas A, Jover R, Hernández V, Quintero E, Lozano JJ, García-Cougil M, Martínez-Arranz I, Castells A, Gironella M, Arroyo R.

Clin Transl Gastroenterol. 2019 Mar;10(3):e00031. doi: 10.14309/ctg.0000000000000031. No abstract available.

6.

Integrated Analysis of Germline and Tumor DNA Identifies New Candidate Genes Involved in Familial Colorectal Cancer.

Díaz-Gay M, Franch-Expósito S, Arnau-Collell C, Park S, Supek F, Muñoz J, Bonjoch L, Gratacós-Mulleras A, Sánchez-Rojas PA, Esteban-Jurado C, Ocaña T, Cuatrecasas M, Vila-Casadesús M, Lozano JJ, Parra G, Laurie S, Beltran S, Consortium E, Castells A, Bujanda L, Cubiella J, Balaguer F, Castellví-Bel S.

Cancers (Basel). 2019 Mar 13;11(3). pii: E362. doi: 10.3390/cancers11030362.

7.

Plasma MicroRNA Signature Validation for Early Detection of Colorectal Cancer.

Herreros-Villanueva M, Duran-Sanchon S, Martín AC, Pérez-Palacios R, Vila-Navarro E, Marcuello M, Diaz-Centeno M, Cubiella J, Diez MS, Bujanda L, Lanas A, Jover R, Hernández V, Quintero E, José Lozano J, García-Cougil M, Martínez-Arranz I, Castells A, Gironella M, Arroyo R.

Clin Transl Gastroenterol. 2019 Jan;10(1):e00003. doi: 10.14309/ctg.0000000000000003. Erratum in: Clin Transl Gastroenterol. 2019 Mar;10(3):e00031.

8.

Lynch-like syndrome is as frequent as Lynch syndrome in early-onset nonfamilial nonpolyposis colorectal cancer.

Antelo M, Golubicki M, Roca E, Mendez G, Carballido M, Iseas S, Cuatrecasas M, Moreira L, Sanchez A, Carballal S, Castells A, Boland CR, Goel A, Balaguer F.

Int J Cancer. 2019 Jan 29. doi: 10.1002/ijc.32160. [Epub ahead of print]

PMID:
30693488
9.

Endoscopic surveillance after colonic polyps and colorrectal cancer resection. 2018 update.

Mangas-Sanjuan C, Jover R, Cubiella J, Marzo-Castillejo M, Balaguer F, Bessa X, Bujanda L, Bustamante M, Castells A, Diaz-Tasende J, Díez-Redondo P, Herráiz M, Mascort-Roca JJ, Pellisé M, Quintero E; Grupo de Cribado del Cáncer Colorrectal de la Sociedad Española de Epidemiología.

Gastroenterol Hepatol. 2019 Mar;42(3):188-201. doi: 10.1016/j.gastrohep.2018.11.001. Epub 2019 Jan 6. Review. English, Spanish.

PMID:
30621911
10.

Detection of serrated lesions in proximal colon by simulated sigmoidoscopy vs faecal immunochemical testing in a multicentre, pragmatic, randomised controlled trial.

Carot L, Castells A, Hernández C, Alvarez-Urturi C, Balaguer F, Lanas A, Cubiella J, Tasende JD, Jover R, Hernandez V, Carballo F, Bujanda L, Quintero E, Andreu M, Bessa X.

United European Gastroenterol J. 2018 Dec;6(10):1527-1537. doi: 10.1177/2050640618804722. Epub 2018 Sep 26.

11.

Changes in FIT values below the threshold of positivity and short-term risk of advanced colorectal neoplasia: Results from a population-based cancer screening program.

Buron A, Román M, Augé JM, Macià F, Grau J, Sala M, Louro J, Martinez-Alonso M, Alvarez-Urturi C, Andreu M, Bessa X, Zaffalon D, Castells A, Pellisé M, Aldea M, Rivero L, Hernández C, Torá-Rocamora I, Castells X.

Eur J Cancer. 2019 Jan;107:53-59. doi: 10.1016/j.ejca.2018.11.004. Epub 2018 Dec 10.

PMID:
30544059
12.

Quantitative analysis of somatically acquired and constitutive uniparental disomy in gastrointestinal cancers.

Torabi K, Erola P, Alvarez-Mora MI, Díaz-Gay M, Ferrer Q, Castells A, Castellví-Bel S, Milà M, Lozano JJ, Miró R, Ried T, Ponsa I, Camps J.

Int J Cancer. 2019 Feb 1;144(3):513-524. doi: 10.1002/ijc.31936. Epub 2018 Dec 3.

PMID:
30350313
13.

Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018.

Vangala DB, Cauchin E, Balmaña J, Wyrwicz L, van Cutsem E, Güller U, Castells A, Carneiro F, Hammel P, Ducreux M, van Laethem JL, Matysiak-Budnik T, Schmiegel W.

Eur J Cancer. 2018 Nov;104:91-103. doi: 10.1016/j.ejca.2018.09.004. Epub 2018 Oct 18.

PMID:
30342310
14.

Colorectal cancer after negative colonoscopy in fecal immunochemical test-positive participants from a colorectal cancer screening program.

Rivero-Sánchez L, Grau J, Augé JM, Moreno L, Pozo A, Serradesanferm A, Díaz M, Carballal S, Sánchez A, Moreira L, Balaguer F, Pellisé M, Castells A; PROCOLON group .

Endosc Int Open. 2018 Sep;6(9):E1140-E1148. doi: 10.1055/a-0650-4296. Epub 2018 Sep 11.

15.

Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.

Murcia O, Juárez M, Rodríguez-Soler M, Hernández-Illán E, Giner-Calabuig M, Alustiza M, Egoavil C, Castillejo A, Alenda C, Barberá V, Mangas-Sanjuan C, Yuste A, Bujanda L, Clofent J, Andreu M, Castells A, Llor X, Zapater P, Jover R.

PLoS One. 2018 Sep 6;13(9):e0203051. doi: 10.1371/journal.pone.0203051. eCollection 2018.

16.

High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome.

Rodríguez-Alcalde D, Carballal S, Moreira L, Hernández L, Rodríguez-Alonso L, Rodríguez-Moranta F, Gonzalo V, Bujanda L, Bessa X, Poves C, Cubiella J, Castro I, González M, Moya E, Oquiñena S, Clofent J, Quintero E, Esteban P, Piñol V, Fernández FJ, Jover R, Cid L, Saperas E, López-Cerón M, Cuatrecasas M, López-Vicente J, Rivero-Sánchez L, Jung G, Vila-Casadesús M, Sánchez A, Castells A, Pellisé M, Balaguer F; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association.

Endoscopy. 2019 Feb;51(2):142-151. doi: 10.1055/a-0656-5557. Epub 2018 Aug 1.

PMID:
30068004
17.

Importance of endoscopist quality metrics for findings at surveillance colonoscopy: The detection-surveillance paradox.

Mangas-Sanjuan C, Zapater P, Cubiella J, Murcia Ó, Bujanda L, Hernández V, Martínez-Ares D, Pellisé M, Seoane A, Lanas Á, Nicolás-Pérez D, Herreros-de-Tejada A, Chaparro M, Cacho G, Fernández-Díez S, Marín-Gabriel JC, Quintero E, Castells A, Jover R; COLONPREV study investigators.

United European Gastroenterol J. 2018 May;6(4):622-629. doi: 10.1177/2050640617745458. Epub 2017 Nov 24.

18.

A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.

Gallardo-Gómez M, Moran S, Páez de la Cadena M, Martínez-Zorzano VS, Rodríguez-Berrocal FJ, Rodríguez-Girondo M, Esteller M, Cubiella J, Bujanda L, Castells A, Balaguer F, Jover R, De Chiara L.

Clin Epigenetics. 2018 Apr 16;10:53. doi: 10.1186/s13148-018-0487-y. eCollection 2018.

19.

TFAP2E Methylation and Expression Status Does Not Predict Response to 5-FU-based Chemotherapy in Colorectal Cancer.

Murcia O, Jover R, Egoavil C, Perez-Carbonell L, Juárez M, Hernández-Illán E, Rojas E, Alenda C, Balaguer F, Andreu M, Llor X, Castells A, Boland CR, Goel A.

Clin Cancer Res. 2018 Jun 15;24(12):2820-2827. doi: 10.1158/1078-0432.CCR-17-2940. Epub 2018 Mar 13.

PMID:
29535127
20.

Tight Junction Protein Claudin-2 Promotes Self-Renewal of Human Colorectal Cancer Stem-like Cells.

Paquet-Fifield S, Koh SL, Cheng L, Beyit LM, Shembrey C, Mølck C, Behrenbruch C, Papin M, Gironella M, Guelfi S, Nasr R, Grillet F, Prudhomme M, Bourgaux JF, Castells A, Pascussi JM, Heriot AG, Puisieux A, Davis MJ, Pannequin J, Hill AF, Sloan EK, Hollande F.

Cancer Res. 2018 Jun 1;78(11):2925-2938. doi: 10.1158/0008-5472.CAN-17-1869. Epub 2018 Mar 6.

PMID:
29510994
21.

Zeb1 in Stromal Myofibroblasts Promotes Kras-Driven Development of Pancreatic Cancer.

Sangrador I, Molero X, Campbell F, Franch-Expósito S, Rovira-Rigau M, Samper E, Domínguez-Fraile M, Fillat C, Castells A, Vaquero EC.

Cancer Res. 2018 May 15;78(10):2624-2637. doi: 10.1158/0008-5472.CAN-17-1882. Epub 2018 Feb 28.

22.

Deciphering microRNA targets in pancreatic cancer using miRComb R package.

Vila-Casadesús M, Vila-Navarro E, Raimondi G, Fillat C, Castells A, Lozano JJ, Gironella M.

Oncotarget. 2018 Jan 8;9(5):6499-6517. doi: 10.18632/oncotarget.24034. eCollection 2018 Jan 19.

23.

Near-tetraploid cancer cells show chromosome instability triggered by replication stress and exhibit enhanced invasiveness.

Wangsa D, Quintanilla I, Torabi K, Vila-Casadesús M, Ercilla A, Klus G, Yuce Z, Galofré C, Cuatrecasas M, Lozano JJ, Agell N, Cimini D, Castells A, Ried T, Camps J.

FASEB J. 2018 Jul;32(7):3502-3517. doi: 10.1096/fj.201700247RR. Epub 2018 Feb 8.

PMID:
29452566
24.

Rare germline copy number variants in colorectal cancer predisposition characterized by exome sequencing analysis.

Franch-Expósito S, Esteban-Jurado C, Garre P, Quintanilla I, Duran-Sanchon S, Díaz-Gay M, Bonjoch L, Cuatrecasas M, Samper E, Muñoz J, Ocaña T, Carballal S, López-Cerón M, Castells A; EPICOLON consortium, Vila-Casadesús M, Derdak S, Laurie S, Beltran S, Carvajal J, Bujanda L, Ruiz-Ponte C, Camps J, Gironella M, Lozano JJ, Balaguer F, Cubiella J, Caldés T, Castellví-Bel S.

J Genet Genomics. 2018 Jan 20;45(1):41-45. doi: 10.1016/j.jgg.2017.12.001. Epub 2017 Dec 20. No abstract available.

PMID:
29396139
25.

An evaluation of the SENTiFIT 270 analyser for quantitation of faecal haemoglobin in the investigation of patients with suspected colorectal cancer.

Auge JM, Rodriguez C, Espanyol O, Rivero L, Sandalinas S, Grau J, Jimenez W, Castells A.

Clin Chem Lab Med. 2018 Mar 28;56(4):625-633. doi: 10.1515/cclm-2017-0605.

PMID:
29150989
26.

Nuclear IGF-1R predicts chemotherapy and targeted therapy resistance in metastatic colorectal cancer.

Codony-Servat J, Cuatrecasas M, Asensio E, Montironi C, Martínez-Cardús A, Marín-Aguilera M, Horndler C, Martínez-Balibrea E, Rubini M, Jares P, Reig O, Victoria I, Gaba L, Martín-Richard M, Alonso V, Escudero P, Fernández-Martos C, Feliu J, Méndez JC, Méndez M, Gallego J, Salud A, Rojo F, Castells A, Prat A, Rosell R, García-Albéniz X, Camps J, Maurel J.

Br J Cancer. 2017 Dec 5;117(12):1777-1786. doi: 10.1038/bjc.2017.279. Epub 2017 Nov 9.

27.

Increased IFRD1 Expression in Human Colon Cancers Predicts Reduced Patient Survival.

Lewis MA, Sharabash N, Miao ZF, Lyons LN, Piccirillo J, Kallogjeri D, Schootman M, Mutch M, Yan Y, Levin MS, Castells A, Cuatrecasas M, Mills JC, Wang ZN, Rubin DC.

Dig Dis Sci. 2017 Dec;62(12):3460-3467. doi: 10.1007/s10620-017-4819-0. Epub 2017 Nov 1.

28.

Impact of comorbid conditions on participation in an organised colorectal cancer screening programme: a cross-sectional study.

Guiriguet C, Pera G, Castells A, Toran P, Grau J, Rivero I, Buron A, Macià F, Vela-Vallespín C, Vilarrubí-Estrella M, Marzo-Castillejo M.

BMC Cancer. 2017 Aug 7;17(1):524. doi: 10.1186/s12885-017-3516-x.

29.

Post-colonoscopy colorectal cancer: Next enemy to beat.

Castells A.

Med Clin (Barc). 2018 Jan 12;150(1):24-25. doi: 10.1016/j.medcli.2017.06.002. Epub 2017 Jul 13. English, Spanish. No abstract available.

PMID:
28711214
30.

Association between socioeconomic deprivation and colorectal cancer screening outcomes: Low uptake rates among the most and least deprived people.

Buron A, Auge JM, Sala M, Román M, Castells A, Macià F, Comas M, Guiriguet C, Bessa X, Castells X; and the PROCOLON research group.

PLoS One. 2017 Jun 16;12(6):e0179864. doi: 10.1371/journal.pone.0179864. eCollection 2017.

31.

Helicobacter pylori Antibody Reactivities and Colorectal Cancer Risk in a Case-control Study in Spain.

Fernández de Larrea-Baz N, Michel A, Romero B, Pérez-Gómez B, Moreno V, Martín V, Dierssen-Sotos T, Jiménez-Moleón JJ, Castilla J, Tardón A, Ruiz I, Peiró R, Tejada A, Chirlaque MD, Butt JA, Olmedo-Requena R, Gómez-Acebo I, Linares P, Boldo E, Castells A, Pawlita M, Castaño-Vinyals G, Kogevinas M, de Sanjosé S, Pollán M, Del Campo R, Waterboer T, Aragonés N.

Front Microbiol. 2017 May 29;8:888. doi: 10.3389/fmicb.2017.00888. eCollection 2017.

32.

POLE and POLD1 screening in 155 patients with multiple polyps and early-onset colorectal cancer.

Esteban-Jurado C, Giménez-Zaragoza D, Muñoz J, Franch-Expósito S, Álvarez-Barona M, Ocaña T, Cuatrecasas M, Carballal S, López-Cerón M, Marti-Solano M, Díaz-Gay M, van Wezel T, Castells A, Bujanda L, Balmaña J, Gonzalo V, Llort G, Ruiz-Ponte C, Cubiella J, Balaguer F, Aligué R, Castellví-Bel S.

Oncotarget. 2017 Apr 18;8(16):26732-26743. doi: 10.18632/oncotarget.15810.

33.

Increased Risk of Colorectal Cancer in Patients With Multiple Serrated Polyps and Their First-Degree Relatives.

Egoavil C, Juárez M, Guarinos C, Rodríguez-Soler M, Hernández-Illán E, Alenda C, Payá A, Castillejo A, Serradesanferm A, Bujanda L, Fernández-Bañares F, Cubiella J, de-Castro L, Guerra A, Aguirre E, Herreros-de-Tejada A, Bessa X, Herráiz M, Marín-Gabriel JC, Balmaña J, Piñol V, Rodríguez Moranta F, Nicolás-Pérez D, Cuatrecasas M, Balaguer F, Castells A, Soto JL, Zapater P, Jover R.

Gastroenterology. 2017 Jul;153(1):106-112.e2. doi: 10.1053/j.gastro.2017.04.003. Epub 2017 Apr 9.

PMID:
28400194
34.

Methylation of WNT target genes AXIN2 and DKK1 as robust biomarkers for recurrence prediction in stage II colon cancer.

Kandimalla R, Linnekamp JF, van Hooff S, Castells A, Llor X, Andreu M, Jover R, Goel A, Medema JP.

Oncogenesis. 2017 Apr 3;6(4):e308. doi: 10.1038/oncsis.2017.9.

35.

Correlation between adenoma detection rate in colonoscopy- and fecal immunochemical testing-based colorectal cancer screening programs.

Cubiella J, Castells A, Andreu M, Bujanda L, Carballo F, Jover R, Lanas Á, Morillas JD, Salas D, Quintero E; COLONPREV study investigators.

United European Gastroenterol J. 2017 Mar;5(2):255-260. doi: 10.1177/2050640616660662. Epub 2016 Jul 20.

36.

Transcription-dependent radial distribution of TCF7L2 regulated genes in chromosome territories.

Torabi K, Wangsa D, Ponsa I, Brown M, Bosch A, Vila-Casadesús M, Karpova TS, Calvo M, Castells A, Miró R, Ried T, Camps J.

Chromosoma. 2017 Oct;126(5):655-667. doi: 10.1007/s00412-017-0629-6. Epub 2017 Mar 25.

PMID:
28343235
37.

Accuracy of Colon Capsule Endoscopy in Detecting Colorectal Polyps in Individuals with Familial Colorectal Cancer: Could We Avoid Colonoscopies?

Alvarez-Urturi C, Fernández-Esparrach G, Ibáñez IA, Rodríguez De Miguel C, Dedeu JM, Bessa X, Córdova H, Pellisé M, Balaguer F, Ginés A, Barranco L, Araujo IK, Andreu M, Llach J, Castells A, González-Suarez B.

Gastroenterol Res Pract. 2017;2017:1507914. doi: 10.1155/2017/1507914. Epub 2017 Feb 7.

38.

Lymph node pooling: a feasible and efficient method of lymph node molecular staging in colorectal carcinoma.

Rakislova N, Montironi C, Aldecoa I, Fernandez E, Bombi JA, Jimeno M, Balaguer F, Pellise M, Castells A, Cuatrecasas M.

J Transl Med. 2017 Jan 14;15(1):14. doi: 10.1186/s12967-016-1114-3.

39.

ZEB1-induced tumourigenesis requires senescence inhibition via activation of DKK1/mutant p53/Mdm2/CtBP and repression of macroH2A1.

de Barrios O, Győrffy B, Fernández-Aceñero MJ, Sánchez-Tilló E, Sánchez-Moral L, Siles L, Esteve-Arenys A, Roué G, Casal JI, Darling DS, Castells A, Postigo A.

Gut. 2017 Apr;66(4):666-682. doi: 10.1136/gutjnl-2015-310838. Epub 2016 Dec 13.

PMID:
27965283
40.

Surveillance of patients with hereditary gastrointestinal cancer syndromes.

Moreira L, Castells A.

Best Pract Res Clin Gastroenterol. 2016 Dec;30(6):923-935. doi: 10.1016/j.bpg.2016.10.004. Epub 2016 Oct 21. Review.

PMID:
27938787
41.

Relationship Between Enterococcus faecalis Infective Endocarditis and Colorectal Neoplasm: Preliminary Results From a Cohort of 154 Patients.

Pericàs JM, Corredoira J, Moreno A, García-País MJ, Falces C, Rabuñal R, Mestres CA, Alonso MP, Marco F, Quintana E, Almela M, Paré JC, Llopis J, Castells A, Miró JM; Hospital Clínic and Hospital Lucus Augusti Infective Endocarditis Investigators.

Rev Esp Cardiol (Engl Ed). 2017 Jun;70(6):451-458. doi: 10.1016/j.rec.2016.10.013. Epub 2017 Mar 9. English, Spanish.

PMID:
27916708
42.

Hereditary forms of colorectal cancer.

Castells A.

Gastroenterol Hepatol. 2016 Sep;39 Suppl 1:62-67. doi: 10.1016/S0210-5705(16)30176-5. Review. English, Spanish.

PMID:
27888866
43.

Candidate predisposing germline copy number variants in early onset colorectal cancer patients.

Brea-Fernandez AJ, Fernandez-Rozadilla C, Alvarez-Barona M, Azuara D, Ginesta MM, Clofent J, de Castro L, Gonzalez D, Andreu M, Bessa X, Llor X, Xicola R, Jover R, Castells A, Castellvi-Bel S, Capella G, Carracedo A, Ruiz-Ponte C.

Clin Transl Oncol. 2017 May;19(5):625-632. doi: 10.1007/s12094-016-1576-z. Epub 2016 Nov 25.

PMID:
27888432
44.

Meat intake, cooking methods and doneness and risk of colorectal tumours in the Spanish multicase-control study (MCC-Spain).

de Batlle J, Gracia-Lavedan E, Romaguera D, Mendez M, Castaño-Vinyals G, Martín V, Aragonés N, Gómez-Acebo I, Olmedo-Requena R, Jimenez-Moleon JJ, Guevara M, Azpiri M, Llorens-Ivorra C, Fernandez-Tardon G, Lorca JA, Huerta JM, Moreno V, Boldo E, Pérez-Gómez B, Castilla J, Fernández-Villa T, Barrio JP, Andreu M, Castells A, Dierssen T, Altzibar JM, Kogevinas M, Pollán M, Amiano P.

Eur J Nutr. 2018 Mar;57(2):643-653. doi: 10.1007/s00394-016-1350-6. Epub 2016 Nov 24.

PMID:
27885555
45.

America, We Are Confused: The Updated U.S. Preventive Services Task Force Recommendation on Colorectal Cancer Screening.

Bretthauer M, Kaminski MF, Hassan C, Kalager M, Holme Ø, Hoff G, Løberg M, Regula J, Castells A, Adami HO.

Ann Intern Med. 2017 Jan 17;166(2):139-140. doi: 10.7326/M16-1805. Epub 2016 Nov 8. No abstract available.

PMID:
27820949
46.

Reassessment colonoscopy to diagnose serrated polyposis syndrome in a colorectal cancer screening population.

Rivero-Sanchez L, Lopez-Ceron M, Carballal S, Moreira L, Bessa X, Serradesanferm A, Pozo A, Augé JM, Ocaña T, Sánchez A, Leoz ML, Cuatrecasas M, Grau J, Llach J, Castells A, Balaguer F, Pellisé M; Procolon Group.

Endoscopy. 2017 Jan;49(1):44-53. doi: 10.1055/s-0042-115640. Epub 2016 Oct 14.

PMID:
27741536
47.

Alerts in electronic medical records in primary care to promote colorectal cancer screening.

Guiriguet C, Castells A.

Br J Gen Pract. 2016 Oct;66(651):513. doi: 10.3399/bjgp16X687301. No abstract available.

48.

Improving survival and local control in rectal cancer in Catalonia (Spain) in the context of centralisation: A full cycle audit assessment.

Manchon-Walsh P, Aliste L, Espinàs JA, Prades J, Guarga A, Balart J, Biondo S, Castells A, Sanjuan X, Tabernero J, Borras JM; Catalonian Rectal Cancer Group.

Eur J Surg Oncol. 2016 Dec;42(12):1873-1880. doi: 10.1016/j.ejso.2016.08.009. Epub 2016 Aug 25.

PMID:
27624916
49.

Incidence of advanced neoplasia during surveillance in high- and intermediate-risk groups of the European colorectal cancer screening guidelines.

Cubiella J, Carballo F, Portillo I, Cruzado Quevedo J, Salas D, Binefa G, Milà N, Hernández C, Andreu M, Terán Á, Arana-Arri E, Ono A, Valverde MJ, Bujanda L, Hernández V, Morillas JD, Jover R, Castells A.

Endoscopy. 2016 Nov;48(11):995-1002. Epub 2016 Aug 2.

PMID:
27485482
50.

Major milestones in translational oncology.

Dragani TA, Castells A, Kulasingam V, Diamandis EP, Earl H, Iams WT, Lovly CM, Sedelaar JP, Schalken JA.

BMC Med. 2016 Jul 28;14(1):110. doi: 10.1186/s12916-016-0654-y.

Supplemental Content

Loading ...
Support Center